BIIB074,
CNV1014802,
raxatrigine,
Raxatrigine,
934240-30-9,
CNV-1014802,
Vixotrigine,
GSK1014802,
UNII-QQS4J85K6Y,
GSK-1014802,
CNV 1014802,
GSK 1014802,
QQS4J85K6Y,
CNV1014802,
GSK1014802(CNV1014802),
(2S,5R)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide,
Raxatrigine [USAN],
BIIB074,
BIIB 074,
2-Pyrrolidinecarboxamide, 5-(4-((2-fluorophenyl)methoxy)phenyl)-, (2S,5R)-,
Vixotrigine [USAN],
GSK2,
Vixotrigine (USAN/INN),
SCHEMBL310473,
CHEMBL3544913,
JESCETIFNOFKEU-SJORKVTESA-N,
EX-A2232,
ZINC34892269,
AKOS027324140,
DB11706,
SB18913,
NCGC00386656-01,
BC600719,
HY-12796,
B5927,
CNV1014802; GSK-1014802; Raxatrigine,
D11179,
(5R)-5-(4-[2-fluorobenzyloxy]phenyl)-L-prolinamide,
(5R)-5-(4-{[(2-Fluorophenyl)methyl]oxy}phenyl)-L-prolinamide,
(2S,5R)-5-(4-(2-FLUOROBENZYLOXY)PHENYL)PYRROLIDINE-2-CARBOXAMIDE,
CS-4038,
GSK1014802?CNV1014802),
(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide HCl,